|
|
|
ĮMONIŲ FINANSŲ
VALDYMAS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Verslo vystymas specialybės studentai |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Atvejų analizė
sąrašas |
|
|
|
|
|
|
|
Prezentacijos
pateikimo savalaikiškumas, skaidrių kokybė, oratorinis menas, auditorijos
įtraukimas į atvejo analizę 0-3 |
Analizuojamos
problemos sudėtingumas 0-3 |
Atvejo analizės
platumas, t.y. pakankamai daug atlikta darbo 0-4 |
Atvejo analizės
gilumas, t.y. panaudoti sudėtingi analizės metodai 0-4 |
Surinkta papildoma,
įdomi ir vertinga medžiaga 0-2 |
Apibendrinimas,
išvados, kas įsimintina, kuo vertingas pateiktas atvejis, kur galima
pritaikyti įgytas žinias 0-2 |
Testo klausimų
kokybė 0-2 |
Oponavimas arba
aktyvus dalyvavimas analizuojant atvejus 0-1 |
|
|
|
|
Eil
Nr. |
Pusl. |
Pavadinimas |
Dalyviai /
Oponentai |
Pristatymo data |
Pristatymo
eilė |
Pristatymo
skaidrės |
Papildoma
medžiaga 1 |
Papildoma
medžiaga 2 |
Vertinimas |
|
1 |
365-369 |
Valuing Capital investment Projects |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
|
|
365-370 |
Valuing Capital investment Projects |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
|
2 |
365-369 |
Valuing Capital investment Projects |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
|
3 |
371-376 |
Merck & Company: Evaluating a Drug Licensing Opportunity |
Miglė
Martusevičiūtė |
2021-10-15 |
2 |
|
|
|
11 |
3 |
2 |
3 |
|
1 |
1 |
|
1 |
|
4 |
371-376 |
Merck & Company: Evaluating a Drug Licensing Opportunity |
Karolina Buckutė |
2021-10-15 |
2 |
|
|
|
10 |
3 |
2 |
3 |
|
1 |
1 |
|
|
|
|
371-376 |
Merck & Company: Evaluating a Drug Licensing Opportunity |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
|
5 |
377-379 |
Tree Values |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
|
6 |
377-379 |
Tree Values |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
|
|
377-379 |
Tree Values |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
|
7 |
381-394 |
The Super Project |
Martynas
Lajauskas |
2021-10-15 |
8 |
|
|
|
10 |
3 |
2 |
1 |
|
1 |
2 |
|
1 |
|
8 |
381-394 |
The Super project |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
|
|
381-394 |
The Super project |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
|
9 |
395-403 |
Net Flix |
Vaiva Marcevičiūtė |
2021-10-15 |
3 |
|
|
|
9 |
3 |
2 |
1 |
|
2 |
1 |
|
|
|
10 |
395-403 |
Net Flix |
Dominykas Černius |
2021-10-15 |
3 |
|
|
|
10 |
3 |
2 |
1 |
|
2 |
1 |
|
1 |
|
11 |
405-418 |
A-Rod: Signing the Best Player in Baseball |
Rokas Gritė |
2021-10-15 |
4 |
|
|
|
10 |
3 |
2 |
2 |
|
1 |
1 |
|
1 |
|
|
405-418 |
A-Rod: Signing the Best Player in Baseball |
Simona
Vaitiekūnaitė |
2021-10-15 |
4 |
|
|
|
10 |
3 |
2 |
2 |
|
1 |
1 |
|
1 |
|
|
405-418 |
A-Rod: Signing the Best Player in Baseball |
Emanuelis Puzakinas |
2021-10-15 |
4 |
|
|
|
10 |
3 |
2 |
2 |
|
1 |
1 |
|
1 |
|
12 |
405-418 |
A-Rod: Signing the Best Player in Baseball |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
|
|
405-418 |
A-Rod: Signing the Best Player in Baseball |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
|
13 |
419-423 |
Ocean Carriers |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
|
14 |
419-423 |
Ocean Carriers |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
|
|
419-423 |
Ocean Carriers |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
|
15 |
405-418 |
Whirlpool Europe |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
|
16 |
405-418 |
Whirlpool Europe |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
|
|
405-418 |
Whirlpool Europe |
Justina
Turauskytė |
2021-10-15 |
1 |
|
|
|
10 |
3 |
2 |
2 |
|
1 |
1 |
|
1 |
|
|
405-418 |
Whirlpool Europe |
Aiva Bulytė |
2021-10-15 |
1 |
|
|
|
10 |
3 |
2 |
2 |
|
1 |
1 |
|
1 |
|
17 |
405-419 |
Whirlpool Europe |
Gintė
Juozėnaitė |
2021-10-15 |
1 |
|
|
|
10 |
3 |
2 |
2 |
|
1 |
1 |
|
1 |
|
18 |
431-435 |
Health Development Corporation |
Povilas
Krikščiūnas |
2021-10-15 |
5 |
|
|
|
10 |
3 |
2 |
2 |
|
1 |
1 |
|
1 |
|
19 |
431-436 |
Health Development Corporation |
Gintarė
Tumėnaitė |
2021-10-15 |
5 |
|
|
|
10 |
3 |
2 |
2 |
|
1 |
1 |
|
1 |
|
20 |
431-437 |
Health Development Corporation |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
|
|
431-443 |
Health Development Corporation |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
|
|
257 |
The Investment Detective
(Investment criteria and discounted cash flow) |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
|
|
257 |
The Investment Detective
(Investment criteria and discounted cash flow) |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
|
|
257 |
The Investment Detective
(Investment criteria and discounted cash flow) |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
|
|
259 |
Worldwide Paper Company
(Analysis of an expansion investment) |
Lukas
Kaškevičius |
2021-10-14 |
1 |
|
|
|
10 |
3 |
2 |
2 |
1 |
|
1 |
|
1 |
|
|
259 |
Worldwide Paper Company
(Analysis of an expansion investment) |
Tadas
Vaitkus |
2021-10-14 |
1 |
|
|
|
9 |
3 |
2 |
2 |
1 |
|
1 |
|
|
|
|
259 |
Worldwide Paper Company
(Analysis of an expansion investment) |
JustasPetraitis |
2021-10-14 |
1 |
|
|
|
9 |
3 |
2 |
2 |
1 |
|
1 |
|
|
|
|
263 |
Target Corporation
(Multifaceted capital investment decisions) |
Titas Meliešius |
2021-10-14 |
2 |
|
|
|
9 |
3 |
2 |
2 |
|
|
2 |
|
|
|
|
263 |
Target Corporation
(Multifaceted capital investment decisions) |
Arnas Meliešius |
2021-10-14 |
2 |
|
|
|
9 |
3 |
2 |
2 |
|
|
2 |
|
|
|
|
263 |
Target Corporation
(Multifaceted capital investment decisions) |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
|
|
283 |
Aurora Textile Company
(Analysis of an automation investment) |
Augustinas
Tvarijonas |
2021-10-11 |
1 |
|
|
|
8 |
3 |
2 |
1 |
|
1 |
1 |
|
|
|
|
283 |
Aurora Textile Company
(Analysis of an automation investment) |
Darius
Valkavičius |
2021-10-11 |
1 |
|
|
|
9 |
3 |
2 |
1 |
|
1 |
1 |
|
1 |
|
|
295 |
Compass Records (Analysis
of working capital investment) |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
|
|
295 |
Compass Records (Analysis
of working capital investment) |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
|
|
295 |
Compass Records (Analysis
of working capital investment) |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
|
|
309 |
Victoria Chemicals plc (A): The Merseyside Project (Relevant cash flows) |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
|
|
309 |
Victoria Chemicals plc (A): The Merseyside Project (Relevant cash flows) |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
|
|
309 |
Victoria Chemicals plc (A): The Merseyside Project (Relevant cash flows) |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
|
|
317 |
Victoria Chemicals plc (B): Merseyside and Rotterdam
Projects (Mutually exclusive
investment opportunities) |
Laurita
Vinciūnaitė |
2021-10-14 |
3 |
|
|
|
10 |
3 |
2 |
2 |
|
|
2 |
|
1 |
|
|
317 |
Victoria Chemicals plc (B): Merseyside and Rotterdam
Projects (Mutually exclusive
investment opportunities) |
Karolina
Ivanauskaitė |
2021-10-14 |
3 |
|
|
|
10 |
3 |
2 |
2 |
|
|
2 |
|
1 |
|
|
317 |
Victoria Chemicals plc (B): Merseyside and Rotterdam
Projects (Mutually exclusive
investment opportunities) |
Žygimantas Jukna |
2021-10-14 |
3 |
|
|
|
10 |
3 |
2 |
2 |
|
|
2 |
|
1 |
|
|
325 |
Euroland Foods S.A.
(Strategic resource allocation) |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
|
|
325 |
Euroland Foods S.A.
(Strategic resource allocation) |
Ugnė Grubinskaitė |
2021-10-15 |
6 |
|
|
|
9 |
3 |
2 |
1 |
|
|
2 |
|
1 |
|
|
325 |
Euroland Foods S.A.
(Strategic resource allocation) |
Miglė Mažonaitė |
2021-10-15 |
6 |
|
|
|
9 |
3 |
2 |
1 |
|
|
2 |
|
1 |
|
|
337 |
Star River Electronics Ltd.(Capital project analysis and
forecasting) |
Tomas
Česnulaitis |
2021-10-15 |
7 |
|
|
|
0 |
|
|
|
|
|
|
|
|
|
|
337 |
Star River Electronics Ltd.(Capital project analysis and
forecasting) |
Kasparu
Černecku |
2021-10-15 |
7 |
|
|
|
0 |
|
|
|
|
|
|
|
|
|
|
337 |
Star River Electronics Ltd.(Capital project analysis and
forecasting) |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
|
1 |
277-296 |
Introduction to Derivative Instruments |
|
|
|
|
|
|
9 |
3 |
2 |
|
2 |
1 |
1 |
|
|
|
2 |
277-296 |
Introduction to Derivative Instruments |
|
|
|
|
|
|
9 |
3 |
2 |
|
2 |
1 |
1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|